STOCK TITAN

Motus GI Holdings Inc - MOTS STOCK NEWS

Welcome to our dedicated news page for Motus GI Holdings (Ticker: MOTS), a resource for investors and traders seeking the latest updates and insights on Motus GI Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Motus GI Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Motus GI Holdings's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.12%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
38.3%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.97%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.38%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.12%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.07%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.17%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.28%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.56%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
conferences
Motus GI Holdings Inc

Nasdaq:MOTS

MOTS Rankings

MOTS Stock Data

2.21M
4.97M
1.17%
3.35%
1.28%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Fort Lauderdale

About MOTS

motus gi holdings, inc. (nasdaq: mots) is a medical technology company based in the u.s., with subsidiaries in the u.s. and israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. the company is focused on the development and commercialization of the pure-vu® system, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. the pure-vu® system is a 510(k) u.s. food and drug administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. the device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. the pure-vu® system has received ce mark approval in europe.